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Abstract 
Alzheimer’s disease (AD) affects temporary memory for bound features more remarkably than for 
individual features. Such selective impairments manifest from presymptomatic through dementia 
stages via titration procedures. A recent study suggested that without titration and with high 
memory load the binding selectivity may disappear in people at risk of AD such as those with Mild 
Cognitive Impairment (MCI). We compared data from two studies on temporary binding which 
assessed people with MCI and controls using different memory loads (2 or 3 items). Selective 
binding impairments were found in MCI, but relative to controls, such selectivity was contingent 
upon memory load (i.e., present with 2 items). Further analysis with MCI people who tested 
positive to neuroimaging biomarkers (i.e., hippocampal atrophy) confirmed that this specific 
binding impairments are a feature of prodromal AD. The temporary binding task has been recently 
suggested by consensus papers as a potential screening tool for AD. The results presented here 
inform on task properties that can maximise the reliability of this new assessment tool for the 
detection of memory impairments in prodromal cases of AD. 
 
 Keywords: Short-term memory binding; Mild Cognitive Impairment; prodromal Alzheimer’s 
disease; Neuropsychological assessment; Early detection 
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Introduction 
 
Memory assessment in individuals at risk of Alzheimer’s disease (AD), such as those with Mild 
Cognitive Impairment (MCI), has long focused on episodic memory functions (Fields, Ferman, 
Boeve, & Smith, 2011; Parra, Abrahams, Logie, Mendez, et al., 2010; Parra et al., 2011). Examples 
are Paired Associates Learning (PAL) tasks (Sahakian et al., 1988), the Face Name Associative 
Memory Exam (FNAME) (Amariglio et al., 2012; Rentz et al., 2013), the Free and Cued Selective 
Reminding test (FCSRT) (E. Barbeau et al., 2004; Buschke, 2014; Grober, Buschke, Crystal, Bang, 
& Dresner, 1988; Sarazin et al., 2007), and other episodic memory tests (Ivanoiu et al., 2005). 
These tests are known to assess functions of the hippocampus which are essential to episodic 
memory formation i.e., associative memory (Tulving, 2002). Tests assessing associative memory 
functions of the hippocampus are considered markers for AD (Auriacombe et al., 2010; E. J. 
Barbeau et al., 2008; Dubois et al., 2010; Rentz et al., 2013; Sarazin et al., 2007). To uphold the 
claim that the associative function is that selectively impaired in AD, it is necessary to demonstrate 
that such impairments are greater than those found when patients remember the individual items. 
For instance, memory for faces (Sperling et al., 2003), lists of words (Gallo, Sullivan, Daffner, 
Schacter, & Budson, 2004), or locations (Stehli, Chubb, & Jacob, 2003), are functions affected by 
AD. This makes it difficult to ascertain that holding associations between these items in memory 
(e.g., faces and locations, faces and names) is the hallmark of AD. This is important because item 
memory and associative memory dissociate (Chalfonte, Verfaellie, Johnson, & Reiss, 1996; Old 
& Naveh-Benjamin, 2008) and the form of representation claimed to be specifically affected by 
the hippocampal amnesia of AD is the latter. This caveat i.e., limited underlying constructs, has 
been recently highlighted by a recent consensus paper (Costa et al., 2017). 
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The Visual Short-Term Memory Binding Test (VSTMBT) was developed to investigate if the 
function responsible for binding features within object representations is affected by AD above 
and beyond that supporting single feature processing (Parra, Abrahams, Logie, & Della Sala, 
2010). The test assesses participants’ memory for single features such as shapes and for 
combination of features such as shape-colour bindings. When memory load is controlled for (i.e., 
via titration to keep patients’ and controls’ memory performance for individual features at the same 
level), patients with AD show memory binding deficits which are far greater than those found 
when memory for single features is assessed (S. Della Sala, Parra, Fabi, Luzzi, & Abrahams, 2012; 
Parra et al., 2009; Parra, Abrahams, Logie, & Della Sala, 2010; Parra, Abrahams, Logie, Mendez, 
et al., 2010; Parra et al., 2011). Such specific increase of the cost of binding has been observed 
since the preclinical stages of AD. This fits well current trends in the assessment of AD which 
have shifted towards a new lexicon (Costa et al., 2017; Dubois et al., 2010; Dubois et al., 2016) 
that encourages the detection of subtle cognitive impairments in stages prior to dementia. The 
VSTMBT detects such early impairments, even when other novel and traditional tests have failed 
(Parra, Abrahams, Logie, Mendez, et al., 2010; Parra et al., 2011).  
The results form a recent study (Koppara et al., 2015) suggest that memory load may be a factor 
precluding the specificity of the VSTMBT (i.e., greater cost of binding in patients than in controls). 
Previous studies have manipulated memory load by presenting patients and controls with a 
different number of to-be-remembered items (Sergio Della Sala, Data, Stamate, & Parra, 2017; S. 
Della Sala et al., 2012; Parra et al., 2009; Parra, Abrahams, Logie, & Della Sala, 2010; Parra, 
Abrahams, Logie, Mendez, et al., 2010; Parra et al., 2011). Such  manipulation  rested on the 
assumption that VSTM stores a limited number of items (Luck & Vogel, 1997; Vogel, Woodman, 
& Luck, 2001) and that increasing the number of items above such a limit (i.e., 4) would overload 
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memory, rendering the task more challenging and performance poorer. Titration aimed at reducing 
differences at baseline (i.e., memory for single features). This led to suggesting that patients with 
AD present with a selective deficit of VSTMB. (Koppara et al., 2015) showed that without titration 
(i.e., patients and controls tested with the same visual arrays of 3 items), the selectivity of the 
VSTMBT holds for people with Subjective Cognitive Deficits (SCD) but not for people with MCI. 
Considering that memory binding is maintained to be selectively impaired in AD and that MCI is 
an uncertain clinical category which holds limited value to predict future risk of dementia, it is 
important to demonstrate the precise testing conditions with which selective impairments of 
VSTMB can be found. Is the specific impaired ability to binding features in VSTM that has been 
considered a hallmark of AD. Hence, identifying such a hallmark in MCI people might provide 
more reliable evidence of AD pathology as the likely underlying mechanism. To address these 
outstanding issues, in the present paper we present data from groups of healthy older adults and 
people with MCI who were assessed with the VSTMBT using arrays of 2 and 3 items and without 
titration. If the above-mentioned selectivity is contingent upon memory load, it would be observed 
only under the low memory load condition (i.e., 2 items). 
 
Methods 
Participants 
Participants came from two separate samples of people with MCI and matched controls assessed 
with different versions of the VSTMBT. One sample was tested with a version of the task 
presenting 2 items, the other sample was assessed with a version presenting 3 items. Table 1 shows 
the demographic, clinical and neuropsychological variables of the participants tested with the two 
set sizes. All participants underwent neuropsychological assessment. People with MCI met criteria 
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proposed by (Petersen, 2004). Participants were fully informed about the study and they signed an 
Informed Consent Form prior to participation. The study was approved by Ethics Committees from 
the Psychology Faculty, Complutense University of Madrid, Clinical University Hospital San 
Carlos from Madrid, and the University Hospital Gregorio Marañón also from Madrid. 
 
The Visual Short-Term Memory Binding Test (VSTMBT) 
The VSTMBT required participants to remember visual arrays in which two or three black shapes 
(Shape Only condition) or coloured shapes (Shape-Colour Binding Condition) were presented for 
2 seconds (Figure 1A). After a brief delay (1 second), a test display appeared showing the same or 
different items all presented in new random locations. The task was to indicate verbally whether 
the study and test display showed the same (50% of the trials) or different items. Different trials in 
the Shape Only condition presented two new shapes at test. Different trials in the Shape-Colour 
Binding condition presented two re-arranged combinations of shape and colour (i.e., two shapes 
swapped their colours at test). Normal perception of shape-colour bindings was ensued prior to the 
VSTMBT. Each condition presented 32 trials in random order. Conditions were counterbalanced 
across participants. We calculated proportion of correct recognition (see (Parra, Abrahams, Logie, 
& Della Sala, 2010), for a detailed description of the task). The above described VSTMBT has 
been used extensively in experimental studies involving different populations with AD dementia 
or at risk of such dementia. More clinically friendly versions of the task (i.e., shorter version on 
PC or flashcard versions; see (Della Sala, et al., 2017)) have been recently developed and validated. 
Using these clinical versions of the test, patients with AD dementia and controls were 
discriminated via ROC analyses with 100% sensitivity and specificity. These versions of the test 
are available for use on request (contact corresponding author). 
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Analysis 
A mixed ANOVA model was used with Group (Controls Set Size 2 vs. people with MCI Set Size 
2 vs. Controls Set Size 3 vs. people with MCI Set Size 3) as the between-subjects factor and 
Condition (Shape Only vs. Shape-Colour Binding) as the within-subjects factor. We calculated 
effect size and power for main effects and interactions.  
 
Results 
The groups were matched on age, education, and depression scores. People with MCI showed a 
profile compatible with the multi-domain amnestic stage. The two groups of people with MCI 
showed a very similar profile of cognitive impairments. Control groups from the two samples did 
not differ in any of the neuropsychological scores (see Table 1). 
 
 
------------------------------------------ 
Insert Table 1 about here 
------------------------------------------ 
 
The ANOVA model revealed a main effect of Group [F(3,100)=24.9, p<0.001, 2=0.43; β=1.0], 
main effect of Condition [F(1,100)=187.14, p<0.001, 2=0.65; β=1.0], and a significant Group x 
Condition Interaction [F(3,100)=6.93, p<0.001, 2=0.17; β=0.97] (Figure 2). To unfold this 
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interaction we ran two separate Group x Condition ANOVAs for each Set Size. For Set Size 3 the 
interaction was non-significant [F(1,50)=2.91, p=0.094, 2=0.05; β=0.39], because of a large drop 
in binding performance in controls. For Set Size 2 it was significant [F(1,50)=14.86, p<0.001, 
2=0.23; β=0.79]. Post-hoc analysis (Table 1) revealed that MCI people’s performance on the 
Shape-Colour Binding condition was disproportionally lower than that on the Shape Only 
condition, a discrepancy not observed in controls. Although these results are appealing, they may 
still face limitations for diagnosis purposes as having MCI and VSTMB deficits may not 
unequivocally inform about the presence of prodromal AD. We ran further analyses using 
neuroimaging data to investigate if such a pattern of selective impairment holds for those who are 
considered biomarker positive (Dubois et al., 2010; Dubois et al., 2016). 
 
Additional Analysis 
A subsample of 17 people with MCI who were assessed with set size 2 underwent MRI scans. The 
volume of their hippocampus was measured and corrected for their intracranial volume. Individual 
hippocampal atrophy was assessed using voxel-based morphometry, as described in (Olazaran et 
al., 2013). Hippocampal volume measurements were calculated using the freely available software 
FreeSurfer (http://surfer.nmr.mgh.harvard.edu/). We used automatic subcortical segmentation 
based upon the existence of an atlas containing probabilistic information on the location of 
structures. We followed the procedures described by Fischl (Fischl et al., 2002). The accuracy of 
FreeSurfer results was then assessed visually for the different participants (Olazaran et al., 2013). 
The extracted volumes were corrected for the total Intra-cranial Volume (ICV). The cut-off to 
identify pathological atrophy was set at -1SD from controls (see Supplementary Figure 1; see also 
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(Jack et al., 1997)). According to these data, 10 participants with MCI show hippocampal atrophy 
(MTA) beyond that expected for their age (-1SD below the control group, see Supplementary 
Figure 1). We ran additional analyses with the VSTMB data collected from this subsample of 
MCI+MTA using the model described above. These analyses revealed that 12 people with MCI 
showed binding deficits that did not overlap with healthy controls’ score, (Figure 1C). Among 
these MCI patients were those considered MCI+MTA (n=10). When the ANOVA model was rerun 
entering solely the data from MCI+MTA, the interaction described above was replicated (Figure 
1D). The pattern shows the selectivity of binding deficits previously reported in AD samples 
(Group x Condition Interaction: F(1,33)=13.07, p=0.001, η2=0.28; β=0.94). 
 
------------------------------------------ 
Insert Figure 1 about here 
------------------------------------------ 
 
Discussion 
The present study was carried out to investigate whether and under what condition people with 
MCI present with the typical pattern of VSTMB impairments consistently found in patients with 
AD dementia. We were driven by the need of providing evidence of the task’s psychometric 
features that can be clinically friendly as within these setting, procedures such as titration of task 
difficulty are unfeasible. We also sought evidence of whether VSTMB deficits in MCI are 
observed in those people who meet criteria for prodromal AD (i.e., significant atrophy of the 
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hippocampus as documented by imaging biomarkers). Below we discuss the main implications of 
our findings. 
Why dissecting memory binding impairments is important? 
There are memory functions the decline of which could be detected prior to the dementia stage of 
AD (e.g., temporary binding abilities). These memory functions have proved both sensitive and 
specific to AD (Cecchini et al., 2017; S. Della Sala et al., 2012; Parra, Abrahams, Logie, & Della 
Sala, 2010). To ascertain whether they are selectively impaired, we need to refine the assessment 
procedures (R. H. Logie, Parra, & Della Sala, 2015). Such developments may enable us to map 
cognitively the continuum of AD. For instance, asymptomatic carriers of the mutation E280A-
PSEN1 leading to familial AD (Parra, Abrahams, Logie, Mendez, et al., 2010) and patients with 
SCD (Koppara et al., 2015) tested under high memory load (3 items) showed selective memory 
binding impairments contrasting with a normal neuropsychological background. Without titration 
and with high memory load, (Koppara et al., 2015) reported that such selectivity disappeared in 
MCI samples. However, when memory load is low, the selectivity of binding is restored in these 
MCI people and mirrors that found in patients with AD dementia (Sergio Della Sala et al., 2017). 
Here we show, for the first time, that MCI people with evidence of hippocampal atrophy 
(MCI+MTA) show significant binding deficits when tested under low memory load condition. 
Interestingly, a subgroup of controls (n=7) showed performance below a recently reported cut-off 
(Sergio Della Sala et al., 2017) despite an intact neuropsychological background.  
A potential account for these findings could be that under high working memory load (n=3) the 
reliance on Medial Temporal Lobe structures such as the hippocampus increases (Doherty & 
Logie, 2016; Unsworth, Brewer, & Spillers, 2013), thus rendering the paradigm less specific (i.e., 
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performance on both conditions will drop). Recent single case studies of neurological patients with 
hippocampal damage (Baddeley, Allen, & Vargha-Khadem, 2010; Jonin et al., 2018; Parra et al., 
2015) confirmed that these patients present with preserved STMB even when memory load was 
higher (3 and 4) than that used with the MCI sample that underwent MRI scans (n=2). However, 
in all cases memory load was below or within the reported capacity of working/short-term memory 
(n=4; (Cowan, 2010)). Future studies with larger samples should investigate if supraspan 
stimulation engages hippocampal functions and if so, whether such involvement reduces the 
specificity of the STMBT to dissect binding deficits in samples at risk of AD. 
 
Our results suggest that titration might not be necessary if the task demands are adjusted to and 
interpreted in line with the different stages of the disease. For example, strategies aimed at 
screening individuals at risk of AD (e.g., asymptomatic mutation carriers of APOE4 genotype or 
other mutations) in whom traditional memory tasks fail (Koppara et al., 2015; Parra, Abrahams, 
Logie, Mendez, et al., 2010), might capitalise on high memory load while those aimed at screening 
in more advanced prodromal stages (i.e., MCI) or at ascertaining the presence of AD, might focus 
on lower memory load (Sergio Della Sala et al., 2017; S. Della Sala et al., 2012; Parra, Abrahams, 
Logie, & Della Sala, 2010). It is worth noting that reducing memory load to 2 items does not 
undermine the need of binding (Parra, Della Sala, Logie, & Morcom, 2014). Hence, use of memory 
strategies, or lack thereof, should not be the factor explaining the selective binding deficits reported 
with this paradigm. There are other psychometric properties of the STMBT that grants reliability 
to this tool for the assessment of AD (R. H. Logie et al., 2015). STMB, as assessed by change 
detection paradigms, has proved to hold internal consistency (R. Logie, Brockmole, & 
Vandenbroucke, 2009). This seems to be a feature of tasks relying on these paradigms (Pailian & 
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Halberda, 2015; Xu, Adam, Fang, & Vogel, 2018). Moreover, the possibility to adjust the task’s 
demands to the severity of the disease to avoid floor and ceiling effects while retaining construct 
validly, is another appealing psychometric property of this novel tool. This latter feature makes 
the task suitable for follow up assessments. However, future studies are still needed to confirm its 
test-retest and inter-rater reliability. 
There might factors other than age and education (see (Koppara et al., 2015; Parra, Abrahams, 
Logie, & Della Sala, 2010)) which can lead to poor performance in healthy ageing populations. 
For instance, in this study, healthy older adults assessed with set size 3 showed a disproportionally 
large cost of binding compared to that reported in earlier studies (Fernández et al., 2018; Koppara 
et al., 2015; Parra, Abrahams, Logie, & Della Sala, 2010). To address this potential limitation a 
task that combines the two set sizes may be a more feasible approach. Alternatively, as recently 
suggested by (Sergio Della Sala et al., 2017), a version presenting binding as the only measure 
drawn from two set sizes could be administered easily and reliably in clinical settings. Older adults 
with poor VSTMB performance might be those in the very early preclinical stages of AD (see 
(Parra, Gazes, & Stern, 2017). these older adults are those experiencing some of 
 
The construct of memory binding in the assessment of AD 
A recent review paper summarises developments of neuropsychological approaches for the 
detection of preclinical AD (Rentz et al., 2013). For example, the FCSRT (Grober, Sanders, Hall, 
& Lipton, 2010), has shown promising results (E. Barbeau et al., 2004; E. J. Barbeau et al., 2008; 
Ivanoiu et al., 2005; Lemos et al., 2016; Sarazin et al., 2007). The Mnemonic Similarity Task 
(MST), which assesses recognition of common items whose similarity to lures is manipulated, has 
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also revealed promising findings (Stark, Yassa, Lacy, & Stark, 2013). Mnemonic discrimination 
relies on pattern separation and such a construct also seems to hold marker properties for AD (E. 
Barbeau et al., 2004; E. J. Barbeau et al., 2008). Performance on such tasks holds the key to 
understanding memory decline along the continuum of AD (Costa et al., 2017; Sperling et al., 
2011). The FCSRT and the MST tax memory functions carried out in LTM. Such functions seem 
to rely on the hippocampus (Bennett, Huffman, & Stark, 2015; Sarazin et al., 2010) which for long 
has been thought of as the earliest target of AD pathology. This view has been recently challenged  
(Didic et al., 2011). (Papp et al., 2015) used the FCSRT and the Memory Capacity Test (MCT, 
recently relabelled as the Memory Binding Test – MBT–  by (Buschke, 2014)) to assess cognitively 
normal older adults who show evidence of brain amyloidosis (Aβ) and neurodegeneration. Z-
scores computed over the whole sample revealed that the MCT, but not the FCSRT, detected 
impairment only in advanced stages. Hence, a substantial amount of brain damage needs to 
accumulate before deficits of LTM binding functions become apparent. However, (Mowrey et al., 
2016) recently investigated the predictive validity of the MBT for incident aMCI. They reported 
that in a longitudinal community-based study of 246 cognitively normal elderly adults aged 70+ 
the MBT significantly predicted incident aMCI within a time window ranging from 4 to 7 years. 
As suggested by (Rentz et al., 2013), more work needs to be done to investigate the added value 
of these promising test for the preclinical detection of AD. Combining in single assessment 
protocols memory tests that assess the sub-hippocampal stages of AD ((Didic et al., 2011), e.g., 
VSTMBT, see also (Wolk, Signoff, & DeKosky, 2008)) and those sensitive to the hippocampal 
stages (MBT/MCT/FCSRT, MST, CANTAB-PAL) to map decline of these functions along the 
AD continuum in larger longitudinal cohorts (see (Costa et al., 2017)), will confirm their value for 
screening and diagnostic purposes.   
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Figure 1. (A) An example trial for each condition of the Short-Term Memory Binding Test using Set Size 2. (B) Mean data from the Short-Term 
Memory Binding Test (error bars = SEM). (C) Overlap between people with Mild Cognitive Impairment (MCI) and Controls in the Shape-Colour 
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Binding condition of the Short-Term Memory Binding Test using Set Size 2. Twelve MCI people did not overlap with controls and fell below the 
cut-off (*) recently reported by (Sergio Della Sala et al., 2017) There were 7 controls whose score were also below such a cut-off. Their 
neuropsychological background and that from controls above cut-off did not significantly differ (see Supplementary Table 1). (D) Mean data from 
the Short-Term Memory Binding Test from Controls and the 10 MCI people who had MRI evidence of hippocampal atrophy.  
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Table 1. Demographic, clinical and neuropsychological variables of subjects tested with the two set sizes. 
  
Set Size 2 Set Size 3 
ANOVA 
Post-Hoc 
Controls (n=25) MCI (n=27) Controls (n=29) MCI (n=23) SS2 SS3 Ctr MCI 
Mean (SD) Range Mean (SD) Range Mean (SD) Range Mean (SD) Range F p 
Ctr 
vs 
MCI 
Ctr 
vs 
MCI 
SS2 
vs 
SS3 
SS2 
vs 
SS3 
Age 74.73 (4.74) (66.00-83.00) 75.07 (5.30) (65.00-87.00) 72.34 (3.76) (68.00-80.00) 75.43 (5.77) (67.00-86.00) 2.25 0.087 1.000 0.157 0.449 1.000 
Education 10.84 (5.02) (4.00-16.00) 10.86 (5.80) (4.00-20.00) 11.00 (5.11) (0.00-20.00) 9.43 (2.90) (6.00-15.00) 0.54 0.655 1.000 1.000 1.000 1.000 
GDS 1.12 (1.96) (0.00-7.00) 2.00 (2.21) (0.00-7.00) 1.28 (2.02) (0.00-9.00) 2.39 (1.90) (0.00-7.00) 2.19 0.094 0.684 0.316 1.000 1.000 
MMSE 27.52 (1.98) (24.00-30.00) 23.90 (2.88) (20.00-29.00) 28.90 (1.23) (26.00-30.00) 25.22 (1.73) (20.00-27.00) 33.42 * 0.001 * 0.101 0.144 
Blessed Scale 0.40 (0.76) (0.00-2.50) 3.05 (2.62) (0.00-10.00) 1.23 (1.54) (0.00-7.00) 3.41 (3.02) (0.00-12.00) 11.31 * * 0.004 0.979 1.000 
TAVEC Imm Free Recall 9.61 (3.34) (0.00-14.00) 4.50 (3.70) (0.00-13.00) 10.52 (2.37) (7.00-16.00) 4.52 (4.04) (0.00-14.00) 24.25 * * * 1.000 1.000 
TAVEC Imm Cued Recall 11.21 (2.11) (7.00-15.00) 6.17 (3.36) (0.00-13.00) 11.97 (2.28) (5.00-16.00) 6.74 (3.54) (1.00-14.00) 29.17 * * * 1.000 1.000 
TAVEC Delayed Free Recall 10.13 (2.97) (0.00-14.00) 4.37 (3.64) (0.00-13.00) 11.31 (1.97) (9.00-16.00) 4.70 (3.73) (0.00-14.00) 35.93 * * * 1.000 1.000 
TAVEC Delayed Cued Recall 11.00 (1.96) (7.00-16.00) 6.73 (3.68) (0.00-15.00) 12.17 (2.24) (7.00-16.00) 6.13 (3.17) (1.00-12.00) 29.57 * * * 0.852 1.000 
TAVEC Recognition 14.58 (1.59) (11.00-16.0) 14.07 (1.89) (9.00-16.00) 14.76 (1.41) (12.00-16.00) 13.74 (2.09) (9.00-16.00) 1.83 0.146 1.000 0.239 1.000 1.000 
TMT-A 58.76 (21.58) (23.00-116.0) 95.80 (56.19) (31.00-260.00) 55.59 (16.06) (26.00-97.00) 116.48 (79.33) (32.00-357.0) 9.21 * 0.038 * 1.000 0.791 
TMT-B 167.64 (93.0) (49.00-360.0) 298.93 (150.86) (117.00-673.0) 156.34 (76.51) (74.00-443.0) 381.23 (231.44) (80.00-929.0) 13.69 * 0.008 * 1.000 0.297 
ROF Copy 28.56 (7.39) (8.00-36.00) 22.92 (9.20) (6.50-36.00) 33.69 (2.88) (25.00-36.00) 28.54 (8.10) (2.50-36.00) 10.83 * 0.033 0.076 0.072 0.037 
ROF Imm Recall 12.48 (6.72) (2.00-29.00) 7.79 (7.06) (0.00-30.00) 16.50 (6.00) (6.00-28.00) 7.22 (4.97) (0.00-17.00) 13.14 * 0.053 * 0.143 1.000 
ROF Delayed Recall 11.23 (6.27) (2.05-26.50) 7.02 (7.04) (0.00-28.00) 16.60 (6.15) (3.00-28.00) 6.80 (4.74) (0.00-18.00) 15.39 * 0.105 * 0.016 1.000 
Letter Fluency (FAS) 34.92 (12.12) (13.00-61.00) 24.03 (8.47) (11.00-42.00) 35.24 (9.53) (14.00-54.00) 27.82 (10.01) (11.00-51.00) 8.43 * 0.001 0.060 1.000 1.000 
Semantic Fluency 61.82 (11.30) (37.00-81.00) 48.87 (11.53) (24.00-80.00) 59.79 (9.44) (45.00-76.00) 43.45 (10.95) (22.00-60.00) 15.82 * * * 1.000 0.463 
VSTM Shape Only 0.94 (0.10) (0.57-1.00) 0.90 (0.11) (0.52-1.00) 0.87 (0.11) (0.53-1.00) 0.70 (0.12) (0.53-0.94) 22.37 * 1.000 * 0.150 * 
VSTM Shape-Colour Binding 0.86 (0.12) (0.51-1.00) 0.68 (0.16) (0.40-0.98) 0.70 (0.11) (0.53-0.97) 0.58 (0.08) (0.41-0.75) 21.01 * * 0.003 * 0.018 
* p < 0.001; Blessed Scale (Blessed, Tomlinson, & Roth, 1968); GDS: Geriatric Depression Scale (Yesavage et al., 1982); Imm: Immediate Recall; 
MMSE: Mini Mental State Examination (Folstein, Folstein, & McHugh, 1975); SS2 & 3: Set Sizes 2 and 3; TAVEC: Spanish version of the California 
Verbal Learning Test (Delis, Kramer, Kaplan, & Ober, 1987).
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